2019, Chronic Condition, Individual and Provider

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2019

Chronic Condition

Individual

Provider

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

MARCH 9, 2023

In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. We’re going to work with training up the providers that already work in these clinical settings to make it a little bit more, essentially, ask this question of how is this going to work in the real world?

Patient-Centered

Patient-Centered Community IT Medical

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

SEPTEMBER 13, 2021

A May 2019 CMS final rule that would have required drug TV advertisements to disclose the WAC of the drug was challenged by a group of pharmaceutical companies and vacated on statutory grounds by the D.C. Drug Price Negotiation to Benefit Medicare and Commercial Plans. Part D currently has no such cap.

Manufacturing

Manufacturing Supply Chain Patient-Centered Utilities

Primary Care Digest

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

Stay Connected